Back to search
FDAFDA · Food and drugs·Recall number Z-2081-2026

Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485

Published May 13, 2026 · Recall initiated: April 1, 2026

Summary

FDA records medical device Class II recall Z-2081-2026, published May 13, 2026 and initiated April 1, 2026. Recalling firm: BioFire Diagnostics, LLC; Status: Ongoing; Reported quantity: 2400 pouches; Lot: Lot Number: 2215125/UDI: 00815381020390. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Respiratory/sore throat panel test may result in false negative results and control failures.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioFire Diagnostics, LLC
Distributor
US Nationwide distribution in the states of MS, TX MN, VA.
Lot
Lot Number: 2215125/UDI: 00815381020390
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485 recalled?

Yes. FDA published recall Z-2081-2026 on May 13, 2026. Reported hazard: Respiratory/sore throat panel test may result in false negative results and control failures.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail